Evidence map›Paper›PMID 23583168›Full record

ReviewCell metabolism2013

Mechanisms and metabolic implications of regional differences among fat depots.

Tamara Tchkonia, Thomas Thomou, Yi Zhu, Iordanes Karagiannides, Charalabos Pothoulakis, Michael D Jensen, James L Kirkland

2 registry-linked trialsOpen access · bronzeAbstract readReview
In one paragraph

Review in Cell metabolism, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 393 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
393citing papers in PubMed, 1 pooled it
26.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04514146 completednot on this mapstarted 2020, after this paper: background citation

A Pilot Study on the Effects of Water-only Fasting and Refeeding on Body Composition and Insulin Resistance

TypeobservationalSponsorTrueNorth Health FoundationRan2020 to 2021Enrolled48ConditionsVisceral Obesity, Insulin ResistanceArmsWater-only fasting
NCT04515095 nacompletednot on this mapstarted 2020, after this paper: background citation

A Safety and Feasibility Study of Water-only Fasting and Refeeding for Treatment of Stage 1 and 2 Hypertensive Patients

TypeinterventionalSponsorTrueNorth Health FoundationRan2020 to 2022Enrolled30ConditionsHypertensionArmsWater-only Fasting
3 · Its place in the literature

Who cites it

393 citing papers in PubMed, 1 synthesis or guideline pooled it, 694 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. 1α,25(OH)Nutrients · 2026
    Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Sexual Dimorphism in the Development of Cardiometabolic Syndrome.Handbook of experimental pharmacology · 2026
    Review
  20. Article

333 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Tamara Tchkonia *Robert and Arlene Kogod Center on Aging.
Thomas Thomou *Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215, USA.
Yi ZhuRobert and Arlene Kogod Center on Aging.
Iordanes KaragiannidesInflammatory Bowel Disease Center, Division of Digestive Diseases, Department of Medicine, University of California at Los Angeles, Los Angeles, CA 90095, USA.
Charalabos PothoulakisInflammatory Bowel Disease Center, Division of Digestive Diseases, Department of Medicine, University of California at Los Angeles, Los Angeles, CA 90095, USA.
Michael D JensenEndocrine Research Unit Mayo Clinic, Rochester, MN 55905, USA.
James L KirklandRobert and Arlene Kogod Center on Aging.
Mayo Clinic in Florida · USUniversity of California, Los Angeles · USHarvard University · US

Funding

Obesity and Energy Metabolism CoreP30DK050456 · NIDDK · UNIVERSITY OF MINNESOTA TWIN CITIES · PI CROW, SCOTT J · 1995 to 2015
$17.0M
REGIONAL FATTY ACID METABOLISM IN HUMANSR01DK045343 · NIDDK · MAYO CLINIC ROCHESTER · PI MICHAEL D. JENSEN · 1992 to 2026
$12.9M
Systems Biology and Bioinformatics CoreP01AG041122 · NIA · MAYO CLINIC ROCHESTER · PI CAMPISI, JUDITH · 2012 to 2016
$9.8M
The Somatotropic Axis and Health Aging: A Search for MechanismsP01AG031736 · NIA · SOUTHERN ILLINOIS UNIVERSITY SCH OF MED · PI BARTKE, ANDRZEJ · 2009 to 2013
$8.4M
FFA METABOLISM IN DIFFERENT TYPES OF HUMAN OBESITYR01DK040484 · NIDDK · MAYO CLINIC ROCHESTER · PI MICHAEL D. JENSEN · 1993 to 2026
$8.2M
Effect of Aging on Preadipocyte DifferentiationR37AG013925 · NIA · MAYO CLINIC ROCHESTER · PI KIRKLAND, JAMES L. · 2016 to 2025
$6.6M
Mechanisms of Neurotensin in Intestinal InflammationR01DK060729 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI POTHOULAKIS, CHARALABOS · 2002 to 2017
$5.0M
SUBSTANCE P AND INTESTINAL INFLAMMATIONR01DK047343 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI POTHOULAKIS, CHARALABOS · 1994 to 2014
$4.2M
Free Fatty Acid Metabolism in Different Types of Human ObesityR37DK040484 · NIDDK · MAYO CLINIC ROCHESTER · PI JENSEN, MICHAEL D. · 2003 to 2012
$4.1M
Effect of Aging on Preadipocyte DifferentiationR01AG013925 · NIA · MAYO CLINIC ROCHESTER · PI KIRKLAND, JAMES L. · 1997 to 2012
$3.7M
Chronic stress mediates fat-related changes in insulin signaling and gut motilityRC1DK086150 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BRADESI, SYLVIE, POTHOULAKIS, CHARALABOS · 2009 to 2010
$983k
FFA METABOLISM IN DIFFERENT TYPES OF HUMAN OBESITYR29DK040484 · NIDDK · MAYO CLINIC COLL OF MEDICINE, ROCHESTER · PI JENSEN, MICHAEL D. · 1988 to 1992
–
NIA NIH HHS AG13925NIA NIH HHS AG31736NIA NIH HHS AG41122NIA NIH HHS P01 AG031736NIA NIH HHS P01 AG041122NIA NIH HHS R01 AG013925NIA NIH HHS R37 AG013925NIDDK NIH HHS DK40484NIDDK NIH HHS DK45343NIDDK NIH HHS DK47343NIDDK NIH HHS DK50456NIDDK NIH HHS DK60729NIDDK NIH HHS DK86150NIDDK NIH HHS P30 DK050456NIDDK NIH HHS R01 DK040484NIDDK NIH HHS R01 DK045343NIDDK NIH HHS R01 DK047343NIDDK NIH HHS R01 DK060729NIDDK NIH HHS R37 DK040484NIDDK NIH HHS RC1 DK086150
6 · The paper itself

Abstract

Fat distribution is closely linked to metabolic disease risk. Distribution varies with sex, genetic background, disease state, certain drugs and hormones, development, and aging. Preadipocyte replication and differentiation, developmental gene expression, susceptibility to apoptosis and cellular senescence, vascularity, inflammatory cell infiltration, and adipokine secretion vary among depots, as do fatty-acid handling and mechanisms of enlargement with positive-energy and loss with negative-energy balance. How interdepot differences in these molecular, cellular, and pathophysiological properties are related is incompletely understood. Whether fat redistribution causes metabolic disease or whether it is a marker of underlying processes that are primarily responsible is an open question.

Indexed as

Adipose TissueAnimalsEnergy MetabolismFatsHumansMetabolic DiseasesFats

Identifiers

PMID23583168
PMCPMC3942783
OpenAlexW2148537305

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.